Evidence map›Paper›PMID 29372452›Full record

ArticleMetabolic brain disease2018

Hibiscus rosa sinensis mediate anxiolytic effect via modulation of ionotropic GABA-A receptors: possible mechanism of action.

Zubia Begum, Ishrat Younus

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Biochemistry and biophysics reports · 2026
    Article
  2. Food science & nutrition · 2025
    Review
  3. Review
  4. Article
  5. Preparative HPLC fraction ofSaudi journal of biological sciences · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zubia BegumDepartment of Pharmacology, Faculty of Pharmacy, Hamdard University, Karachi, Pakistan.
Ishrat YounusDepartment of Pharmacology, Faculty of Pharmacy, Hamdard University, Karachi, Pakistan. ishratyounas@gmail.com.ORCID 0000-0002-7032-6677
Hamdard University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study was designed with the aim to investigate anti-anxiety potential of Hibiscus rosa sinensis roots and its possible mechanism of action. For this purpose hole board test, elevated plus maze test and light/dark exploration test were employed. The ethanol extract of plant was administered orally at two different doses i.e. 100 and 500 mg/kg for consecutive 14 days. The results of present investigation indicate that plant extract significantly (p < 0.05) increased the number of head dips and rearings as compared to control on respective days of observation. The extract increased the time of permanence in open arms and the number of head dips in elevated plus maze. In light/dark test, our study indicate that Hibiscus rosa sinensis significantly (p < 0.05) increased the time spent in light compartment and number of entries as compared to control. In addition the anxiolytic effects of HRS at highest tested dose were blocked by flumazenil, a GABA-A receptor antagonist that indicate that Hibiscus rosa sinensis potentiated the GABAergic actions. The results propose that the ethanol extract of Hibiscus rosa sinensis has prospective anxiolytic effect in mice via inhibition of ionotropic GABA receptors, using different behavioral paradigms.

Indexed as

AnimalsAnti-Anxiety AgentsAnxietyGABA-A Receptor AntagonistsHibiscusMaleMicePlant ExtractsPlant RootsReceptors, GABA-ARosaAnti-Anxiety AgentsGABA-A Receptor AntagonistsPlant ExtractsReceptors, GABA-AAnxiolyticDiazepamEthanol extractFlumazenilHibiscus rosa sinensisMice

Identifiers

PMID29372452
OpenAlexW2791683483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.